Why MannKind Stock Soared 19% Higher on Tuesday
Commercial-stage biotech MannKind (NASDAQ: MNKD) was a top choice of investors on the second day of the trading week. Tuesday saw MannKind's share price leap by almost 19%, making it stand out on a day when the S 500 index slumped by 0.4%.
The reason for the stock's jump wasn't hard to tease out.
MannKind, which concentrates on developing treatments for endocrine and lung disorders, published its second quarter results that day.
Source Fool.com
MannKind Corp. Stock
€3.31
-0.570%
With 27 Buy predictions and not a single Sell prediction MannKind Corp. is an absolute favorite of our community.
With a target price of 7 € there is potential for a 111.8% increase which would mean more than doubling the current price of 3.31 € for MannKind Corp..


